Insider Cluster (2 insiders) ·Filed Aug 28, 2026

CORT

CORCEPT THERAPEUTICS INC
NEUTRAL
Impact 2/10
Horizondays Processed28d 18h ago
Insider cluster: 2 insiders, $4.0M total
Actionable Insight • Neutral

This cluster is too small relative to market cap to warrant a bearish read. Monitor for any upcoming 8-K or earnings release that could have motivated the sales, but the dollar amounts suggest diversification or tax planning, not informed selling.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d ⚠ clustered
CORT ▲ +1.54% at T+20d
NEUTRAL call ✓ call won +1.54% · α vs SPY +1.28% · entry $113.88 → $115.63
Next anchor: T+60d in 7w
Latest observation: T+22 -15.73% FF3 residual α
Entry anchored
Aug 27, 07:53 PM ET
via 1-min bar
T+1d
-0.47%
call -0.47% · α -0.17%
$113.35
settled 5w ago
T+5d
-1.98%
call -1.98% · α -2.09%
$111.62
settled 29d ago
T+20d
+1.54%
call +1.54% · α +1.28%
$115.63
settled 7d ago
T+60d
—
call — · α —
—
in 7w

Price Chart

Loading chart...

Executive Summary

Two Corcept Therapeutics insiders sold a combined $4.01M in stock over a week, including a Director's $3.27M sale. The total value represents ~0.034% of the $11.9B market cap, which is well below the 0.1% materiality threshold, making this a routine liquidity-driven cluster. No C-suite executives participated, and the sales lack the proportionality to signal bearish conviction.

Key Financial Metrics

Direction
selling
Total Value
$4.0M
Insiders
2

Key Facts

  • Director Park Kimberly sold 26.7K shares for $3.27M on 2026-08-26
  • Officer Maduck Sean sold 5.9K shares for $740K on 2026-08-25
  • Total cluster value of $4.01M is only ~0.034% of CORT's $11.9B market cap
  • No CEO, CFO, or other C-suite executives participated in the cluster
  • Two additional non-cash transactions (grant/award and tax withholding) by a separate officer occurred on 2026-09-01, but are $0 economic events

Financial Impact

Total insider sales of $4.01M represent ~0.034% of market cap — trivial and routine

dilution

Risk Factors

  • Insider sales could accelerate if the stock continues its recent upward trajectory
  • No C-suite participation reduces the informational value of this cluster

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
83% bullish (12 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-CORT-1788483682832
26 reports for CORT
Performance horizon
100% Hit rate 7 of 7 directional calls best @ T+60▲ +63.06%Feb 24, 2026
Filters
Rows
Reports for CORT — sortable, filterable
TypeNow
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$113.88 $115.63▲ +1.54%▲ +1.28%$116.49 (+2.29%)
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$113.88 $116.10▲ +1.95%▲ +1.44%$116.49 (+2.29%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$116.93 $117.00▲ +0.06%▲ +0.16%$116.49 (−0.38%)
Aug 20, 2026
6w ago
Insider Cluster
NEUTRAL ★ 4/10
$121.05 $114.86▼ −5.11%▼ −5.11%$116.49 (−3.77%)
Aug 18, 2026
6w ago
Insider Cluster
BEARISH ★ 4/10
$118.10 $111.85▲ +5.29%▲ +4.30%$116.49 (+1.36%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$112.18 $114.92▲ +2.44%▲ +4.34%$116.49 (+3.84%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$112.18 $114.92▲ +2.44%▲ +4.34%$116.49 (+3.84%)
Aug 6, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$110.77 $111.62▲ +0.77%▲ +1.16%$116.49 (+5.16%)
Aug 5, 2026
8w ago
Insider Cluster
NEUTRAL ★ 3/10
$107.95 $112.80▲ +4.49%▲ +3.89%$116.49 (+7.91%)
Jul 23, 2026
10w ago
Court Ruling
BULLISH ★ 4/10
$96.66 $121.05▲ +25.23%▲ +21.92%$116.49 (+20.52%)
Showing 10 of 26

US Market Status

Market Open — Closes in 52m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Sep 4, 2026